Simpler Grants.gov #356044

FDA Cooperative Agreement for Center for Research on Complex Generics

The Food and Drug Administration (FDA) is seeking to establish a Center for Research on Complex Generics through a cooperative agreement. - Government Buyer: - Food and Drug Administration (FDA) - OEMs and Vendors: - No specific OEMs or vendors are named; opportunity is open to a wide range of eligible applicants including government entities, educational institutions, nonprofits, and businesses - Products/Services Requested: - Establishment and operation of a Center for Research on Complex Generics - Facilitate engagement with generic drug industry representatives - Provide a collaborative forum for stakeholders - Coordinate and conduct research projects focused on complex generic drugs - Host scientific workshops and provide training - Support educational activities related to generic drugs - Ensure public access to research outcomes (articles, posters, presentations) - Unique or Notable Requirements: - Emphasis on collaboration between FDA, academia, and the generic drug industry - Focus on research and education for complex generics - Public dissemination of research findings - Only one award is expected, valued at $1,500,000

Description

The Food and Drug Administration (FDA) seeks to fund a Center for Research on Complex Generics through a cooperative agreement. The Center will support FDA's efforts to enhance collaborations with the generic drug industry to increase patient access to high-quality, safe, and effective generic drugs. Goals include facilitating engagement with industry representatives, providing a forum for collaboration, coordinating research projects on complex generics, hosting scientific workshops, and providing public access to research outcomes. The Center aims to complement FDA's existing programs by serving as a hub for coordination and engagement with stakeholders.

View original listing